{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:19:18Z","timestamp":1790223558268,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7743","license":[{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T00:00:00Z","timestamp":1548806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"published-print":{"date-parts":[[2019,2,14]]},"DOI":"10.1038\/s41586-019-0895-y","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T14:03:40Z","timestamp":1548857020000},"page":"264-269","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["PKG1-modified TSC2 regulates mTORC1 activity to counter adverse cardiac stress"],"prefix":"10.1038","volume":"566","author":[{"given":"Mark J.","family":"Ranek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen M.","family":"Kokkonen-Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany L.","family":"Dunkerly-Eyring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Pinilla","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian U.","family":"Oeing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag H.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taishi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangshuo","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djahida","family":"Bedja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J.","family":"Holewinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Van Eyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Ik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Kass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,30]]},"reference":[{"key":"895_CR1","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960\u2013976 (2017).","journal-title":"Cell"},{"key":"895_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1161\/CIRCRESAHA.117.311147","volume":"122","author":"S Sciarretta","year":"2018","unstructured":"Sciarretta, S., Forte, M., Frati, G. & Sadoshima, J. New insights into the role of mTOR signaling in the cardiovascular system. Circ. Res. 122, 489\u2013505 (2018).","journal-title":"Circ. Res."},{"key":"895_CR3","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nature13492","volume":"513","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. Coordinated regulation of protein synthesis and degradation by mTORC1. Nature 513, 440\u2013443 (2014).","journal-title":"Nature"},{"key":"895_CR4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.cell.2005.02.031","volume":"121","author":"L Ma","year":"2005","unstructured":"Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P. & Pandolfi, P. P. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121, 179\u2013193 (2005).","journal-title":"Cell"},{"key":"895_CR5","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/ncb840","volume":"4","author":"CJ Potter","year":"2002","unstructured":"Potter, C. J., Pedraza, L. G. & Xu, T. Akt regulates growth by directly phosphorylating Tsc2. Nat. Cell Biol. 4, 658\u2013665 (2002).","journal-title":"Nat. Cell Biol."},{"key":"895_CR6","doi-asserted-by":"publisher","first-page":"13489","DOI":"10.1073\/pnas.0405659101","volume":"101","author":"PP Roux","year":"2004","unstructured":"Roux, P. P., Ballif, B. A., Anjum, R., Gygi, S. P. & Blenis, J. Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc. Natl Acad. Sci. USA 101, 13489\u201313494 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"895_CR7","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cell.2013.11.049","volume":"156","author":"S Menon","year":"2014","unstructured":"Menon, S. et al. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell 156, 771\u2013785 (2014).","journal-title":"Cell"},{"key":"895_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","volume":"115","author":"K Inoki","year":"2003","unstructured":"Inoki, K., Zhu, T. & Guan, K. L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577\u2013590 (2003).","journal-title":"Cell"},{"key":"895_CR9","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","volume":"126","author":"K Inoki","year":"2006","unstructured":"Inoki, K. et al. TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell 126, 955\u2013968 (2006).","journal-title":"Cell"},{"key":"895_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature14332","volume":"519","author":"DI Lee","year":"2015","unstructured":"Lee, D. I. et al. Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease. Nature 519, 472\u2013476 (2015).","journal-title":"Nature"},{"key":"895_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/164_2016_82","volume":"243","author":"GE Kim","year":"2016","unstructured":"Kim, G. E. & Kass, D. A. Cardiac phosphodiesterases and their modulation for treating heart disease. Handb. Exp. Pharmacol. 243, 249\u2013269 (2016).","journal-title":"Handb. Exp. Pharmacol."},{"key":"895_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nm1175","volume":"11","author":"E Takimoto","year":"2005","unstructured":"Takimoto, E. et al. Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat. Med. 11, 214\u2013222 (2005).","journal-title":"Nat. Med."},{"key":"895_CR13","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1161\/CIRCRESAHA.109.208314","volume":"106","author":"H Kinoshita","year":"2010","unstructured":"Kinoshita, H. et al. Inhibition of TRPC6 channel activity contributes to the antihypertrophic effects of natriuretic peptides\u2013guanylyl cyclase-A signaling in the heart. Circ. Res. 106, 1849\u20131860 (2010).","journal-title":"Circ. Res."},{"key":"895_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim, J., Kundu, M., Viollet, B. & Guan, K. L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132\u2013141 (2011).","journal-title":"Nat. Cell Biol."},{"key":"895_CR15","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1089\/ars.2010.3488","volume":"14","author":"N Hariharan","year":"2011","unstructured":"Hariharan, N., Zhai, P. & Sadoshima, J. Oxidative stress stimulates autophagic flux during ischemia\/reperfusion. Antioxid. Redox Signal. 14, 2179\u20132190 (2011).","journal-title":"Antioxid. Redox Signal."},{"key":"895_CR16","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1073\/pnas.0409143102","volume":"102","author":"BA Ballif","year":"2005","unstructured":"Ballif, B. A. et al. Quantitative phosphorylation profiling of the ERK\/p90 ribosomal S6 kinase-signaling cassette and its targets, the tuberous sclerosis tumor suppressors. Proc. Natl Acad. Sci. USA 102, 667\u2013672 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"895_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","volume":"534","author":"P Mertins","year":"2016","unstructured":"Mertins, P. et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55\u201362 (2016).","journal-title":"Nature"},{"key":"895_CR18","doi-asserted-by":"publisher","first-page":"36051","DOI":"10.1074\/jbc.M112.394726","volume":"287","author":"A Wong","year":"2012","unstructured":"Wong, A., Zhang, Y. W., Jeschke, G. R., Turk, B. E. & Rudnick, G. Cyclic GMP-dependent stimulation of serotonin transport does not involve direct transporter phosphorylation by cGMP-dependent protein kinase. J. Biol. Chem. 287, 36051\u201336058 (2012).","journal-title":"J. Biol. Chem."},{"key":"895_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nmeth1048","volume":"4","author":"JJ Allen","year":"2007","unstructured":"Allen, J. J. et al. A semisynthetic epitope for kinase substrates. Nat. Methods 4, 511\u2013516 (2007).","journal-title":"Nat. Methods"},{"key":"895_CR20","doi-asserted-by":"publisher","first-page":"e0152628","DOI":"10.1371\/journal.pone.0152628","volume":"11","author":"M Taneike","year":"2016","unstructured":"Taneike, M. et al. mTOR hyperactivation by ablation of tuberous sclerosis complex 2 in the mouse heart induces cardiac dysfunction with the increased number of small mitochondria mediated through the down-regulation of autophagy. PLoS ONE 11, e0152628 (2016).","journal-title":"PLoS ONE"},{"key":"895_CR21","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1172\/JCI43008","volume":"120","author":"D Zhang","year":"2010","unstructured":"Zhang, D. et al. mTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J. Clin. Invest. 120, 2805\u20132816 (2010).","journal-title":"J. Clin. Invest."},{"key":"895_CR22","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.110.977066","volume":"123","author":"P Shende","year":"2011","unstructured":"Shende, P. et al. Cardiac raptor ablation impairs adaptive hypertrophy, alters metabolic gene expression, and causes heart failure in mice. Circulation 123, 1073\u20131082 (2011).","journal-title":"Circulation"},{"key":"895_CR23","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.yjmcc.2007.09.015","volume":"43","author":"PC Moschella","year":"2007","unstructured":"Moschella, P. C., Rao, V. U., McDermott, P. J. & Kuppuswamy, D. Regulation of mTOR and S6K1 activation by the nPKC isoforms, PKC\u03b5 and PKC\u03b4, in adult cardiac muscle cells. J. Mol. Cell. Cardiol. 43, 754\u2013766 (2007).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"895_CR24","doi-asserted-by":"publisher","first-page":"27111","DOI":"10.1074\/jbc.M111.260794","volume":"286","author":"BD Fonseca","year":"2011","unstructured":"Fonseca, B. D. et al. Pharmacological and genetic evaluation of proposed roles of mitogen-activated protein kinase\/extracellular signal-regulated kinase kinase (MEK), extracellular signal-regulated kinase (ERK), and p90RSK in the control of mTORC1 protein signaling by phorbol esters. J. Biol. Chem. 286, 27111\u201327122 (2011).","journal-title":"J. Biol. Chem."},{"key":"895_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5516","volume":"5","author":"V Ranganathan","year":"2014","unstructured":"Ranganathan, V., Wahlin, K., Maruotti, J. & Zack, D. J. Expansion of the CRISPR\u2013Cas9 genome targeting space through the use of H1 promoter-expressed guide RNAs. Nat. Commun. 5, 4516 (2014).","journal-title":"Nat. Commun."},{"key":"895_CR26","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR\u2013Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"895_CR27","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1172\/JCI200317222","volume":"112","author":"H Zhang","year":"2003","unstructured":"Zhang, H. et al. Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K\u2013Akt signaling through downregulation of PDGFR. J. Clin. Invest. 112, 1223\u20131233 (2003).","journal-title":"J. Clin. Invest."},{"key":"895_CR28","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1172\/JCI80275","volume":"125","author":"T Nakamura","year":"2015","unstructured":"Nakamura, T. et al. Prevention of PKG1\u03b1 oxidation augments cardioprotection in the stressed heart. J. Clin. Invest. 125, 2468\u20132472 (2015).","journal-title":"J. Clin. Invest."},{"key":"895_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13187","volume":"7","author":"J Scotcher","year":"2016","unstructured":"Scotcher, J. et al. Disulfide-activated protein kinase G I\u03b1 regulates cardiac diastolic relaxation and fine-tunes the Frank\u2013Starling response. Nat. Commun. 7, 13187 (2016).","journal-title":"Nat. Commun."}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-019-0895-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-019-0895-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-019-0895-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T19:16:51Z","timestamp":1732735011000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-019-0895-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,30]]},"references-count":29,"journal-issue":{"issue":"7743","published-print":{"date-parts":[[2019,2,14]]}},"alternative-id":["895"],"URL":"https:\/\/doi.org\/10.1038\/s41586-019-0895-y","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,30]]},"assertion":[{"value":"4 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.A.K., J.D.P., M.J.R., K.M.K.-S. and C.H.P. are co-inventors on a patent application (PCT: 448070145WO1) that was filed in July 2018 (provisional filed in June 2017). The patent relates to the use of TSC2(S1365\/S1364) modifications for immunological applications. D.A.K., J.D.P. and M.J.R. are co-founders and shareholders of Meta-T Cellular, a start-up company that aims to develop applications of this intellectual property for immune therapy.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}